Cafepharma Today

December 20 2024 - Novo’s next-gen obesity drug misses expectations in closely watched trial
Novo’s next-gen obesity drug misses expectations in closely watched trial
Phase III MASH miss sends Galectin stock tumbling
Why the drug industry and its friends are holding their fire on RFK Jr.
Zepbound, Mounjaro shortages are resolved, FDA confirms
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Medicis Pharmaceutical Corporation
Yahoo
Saturday, October 11, 2008 - 12:04pm
tags:
FDA Continues Review Of Takeda's New Drug Application For Alogliptin (SYR-322), A DPP-4 Agent For Type 2 Diabetes
Medical News Today
Saturday, October 11, 2008 - 12:02pm
tags:
Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberté(R) drug-eluting stent
CNW Telbec
Saturday, October 11, 2008 - 12:01pm
tags:
When There Is Blood In The Streets - Buy Biotech
istockanalyst
Saturday, October 11, 2008 - 11:57am
tags:
Lorus Therapeutics Announces Voluntary Delisting From the NYSE
IT Business Net
Saturday, October 11, 2008 - 11:56am
tags:
Eli Lilly's Lesson in Long-Term Thinking
The Street
Saturday, October 11, 2008 - 11:51am
tags:
ImClone vs. GM — No Contest on Market Capitalization
Wall Street Journal
Saturday, October 11, 2008 - 11:50am
tags:
Investors Overreacting to Biogen Choice?
Yahoo
Saturday, October 11, 2008 - 11:48am
tags:
Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
Yahoo
Saturday, October 11, 2008 - 11:45am
tags:
Biotech Earnings Preview: A Place to Hide?
The Street
Saturday, October 11, 2008 - 11:44am
tags:
FDA delays review of Takeda's alogliptin
Fierce Biotech
Friday, October 10, 2008 - 10:28am
tags:
Crisis will spur new biotech deals on worse terms
Fierce Biotech
Friday, October 10, 2008 - 10:28am
tags:
Drug firms agree to invest more in AIDS research-UN
Reuters
Friday, October 10, 2008 - 10:27am
tags:
Watson reports positive results from overactive bladder study
Trading Markets
Friday, October 10, 2008 - 10:26am
tags:
Analysts brush off Biogen Idec's decision to end development of experimental arthritis drug
Yahoo/AP
Friday, October 10, 2008 - 9:31am
tags:
FDA approves AstraZeneca's SEROQUEL XR Extended-Release Tablets for bipolar disorder
RTT News
Friday, October 10, 2008 - 9:30am
tags:
Merck’s Gardasil Given to 1 in 4 Teenage Girls
WSJ Online
Friday, October 10, 2008 - 9:17am
tags:
Abbott Labs Shows Textbook Case For Turnaround
Investopedia
Friday, October 10, 2008 - 9:08am
tags:
FDA approves arm injection site for Alkermes and J&J's schizophrenia drug Risperdal
Yahoo/AP
Friday, October 10, 2008 - 9:07am
tags:
Shionogi Completes Acquisition of Sciele
Yahoo
Friday, October 10, 2008 - 9:05am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline
White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels
PPAR Binding Strikes Again
In the Pipeline
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
Bad Bar Graphs
In the Pipeline

Latest Jobs

EP Senior Mapping Specialist - Bay Area, CA
San Francisco, California, 94199
Boston Scientific Gruppe
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Sr. Training Manager, Learning & Performance
Yardley, Pennsylvania, 19067
EVERSANA
Area Manager, Immunology West Central Tulsa
Coffeyville, Kansas, 67337
CSL Behring
staff - Registered Nurse (RN) - Clinical Liaison - $80K-90K per year
Houston, Texas, 77246
AccentCare
Pharmaceutical Sales Customer Engagement - Kalamazoo, MI
Michigan, ,
Otsuka
Pharmaceutical Sales Customer Engagement - Wilmington, NC
North Carolina, ,
Otsuka
Pharmaceutical Sales Customer Engagement- Valparaiso, IN
Valparaiso, Indiana,
Otsuka
Area Manager-Specialty Northeast, Albany
Fields, Oregon, 97710
CSL Behring
Pharmaceutical Sales Customer Engagement - Atlanta S, GA
Atlanta, Georgia,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information